Pioglitazone enhances cisplatin’s impact on triple-negative breast cancer: Role of PPARγ in cell apoptosis

Peroxisome proliferator-activated receptor-gamma (PPARγ) has been recently shown to play a role in many cancers. The breast tissue of triple-negative breast cancer (TNBC) patients were found to have a significantly lower expression of PPARγ than the other subtypes. Furthermore, PPARγ activation was...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Qamraa Hamad Alqahtani, Layla Abdullah Alkharashi, Hanaa Alajami, Ishraq Alkharashi, Layan Alkharashi, Shoug Nasser Alhinti
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	Springer 2024-05-01
Saila:	Saudi Pharmaceutical Journal
Gaiak:	Pioglitazone Cisplatin Triple-negative breast cancer PPARγ Apoptosis
Sarrera elektronikoa:	http://www.sciencedirect.com/science/article/pii/S1319016424001099
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!